×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Zynerba Pharmaceuticals Inc. (ZYNE) NASDAQ

$1.30 - (-)

Market Cap: -

As of 10/10/23 12:00 AM EDT. Market closed.

(ZYNE)

Zynerba Pharmaceuticals Inc. (ZYNE)
NASDAQ

$1.30
- (-)

Market Cap: -

As of 10/10/23 12:00 AM EDT. Market closed.

Add to Portfolio

at zynerba pharmaceuticals (nasdaq: zyne), we are dedicated to developing next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. our mission is to improve the lives of patients battling severe health conditions including refractory epilepsy, osteoarthritis, fragile x syndrome, fibromyalgia and peripheral neuropathic pain ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
URL
Address
80 W. Lancaster Avenue, Suite 300, Pennsylvania, Devon, 19333.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Armando Anido
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
Address
80 W. Lancaster Avenue, Suite 300, Pennsylvania, Devon, 19333.
PRICE CHART FOR ZYNERBA PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.30
Days Range
$1.26 - $1.34
52 week range
- - -
Volume
862,786
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
53,939,431
Open
-
Previous Close
$1.30
Days Range
$1.26 - $1.34
52 week range
- - -
Volume
862,786
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
53,939,431
FINANCIAL STATEMENTS FOR ZYNERBA PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ZYNERBA PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Sebree Terri BPresidentSep 13, 2023 Sale$1.3312,40116,440596,241Sep 14, 2023, 04:14 PM
Rosenberger BrianVP, Commercial & Business Dev.Sep 13, 2023 Sale$1.336,4118,499249,559Sep 14, 2023, 04:14 PM
Fickenscher James EChief Financial OfficerSep 13, 2023 Sale$1.338,99811,929378,087Sep 14, 2023, 04:13 PM
Jones Kenneth TSee RemarksSep 13, 2023 Sale$1.332,5053,32185,520Sep 14, 2023, 04:13 PM
ANIDO ARMANDOChairman & Chief Exec. OfficerSep 13, 2023 Sale$1.3317,83023,637936,722Sep 14, 2023, 04:13 PM
Stephenson PamelaDirectorJun 14, 2023 Sale$0.351154075,778Jun 15, 2023, 04:30 PM
MOCH KENNETH IDirectorJun 14, 2023 Sale$0.351154075,778Jun 15, 2023, 04:30 PM
KISNER DANIEL LDirectorJun 14, 2023 Sale$0.351154075,778Jun 15, 2023, 04:29 PM
FEDERICI WILLIAM JDirectorJun 14, 2023 Sale$0.351154075,778Jun 15, 2023, 04:29 PM
Butler John P.DirectorJun 14, 2023 Sale$0.351154080,765Jun 15, 2023, 04:28 PM
COOPER WARREN DDirectorJun 14, 2023 Sale$0.351154075,778Jun 15, 2023, 04:28 PM
Parker Albert PChief Legal OfficerFeb 15, 2023 Sale$0.543,1731,719227,018Feb 17, 2023, 04:21 PM
Rosenberger BrianVP, Commercial & Business Dev.Feb 08, 2023 Option Exercise$0.605,1453,069233,770Feb 09, 2023, 05:20 PM
Fickenscher James EChief Financial OfficerFeb 08, 2023 Option Exercise$0.606,5443,903355,885Feb 09, 2023, 05:11 PM
Sebree Terri BPresidentFeb 08, 2023 Option Exercise$0.609,9735,949563,642Feb 09, 2023, 05:11 PM
ANIDO ARMANDOChairman & Chief Exec. OfficerFeb 08, 2023 Option Exercise$0.6012,5477,484889,805Feb 09, 2023, 05:10 PM
Parker Albert PChief Legal OfficerFeb 08, 2023 Option Exercise$0.605,4633,259230,191Feb 09, 2023, 05:09 PM
ANIDO ARMANDOChairman & Chief Exec. OfficerFeb 01, 2023 Option Exercise$0.6011,7266,979856,946Feb 02, 2023, 08:13 PM
Parker Albert PChief Legal OfficerFeb 01, 2023 Option Exercise$0.605,8413,477216,790Feb 02, 2023, 08:12 PM
Rosenberger BrianVP, Commercial & Business Dev.Feb 01, 2023 Option Exercise$0.604,8092,862223,989Feb 02, 2023, 08:10 PM
Fickenscher James EChief Financial OfficerFeb 01, 2023 Option Exercise$0.605,9273,528339,882Feb 02, 2023, 08:08 PM
Sebree Terri BPresidentFeb 01, 2023 Option Exercise$0.609,3215,548537,571Feb 02, 2023, 08:06 PM
Sebree Terri BPresidentJan 23, 2023 Sale$0.6024,66114,742343,204Jan 25, 2023, 05:29 PM
Fickenscher James EChief Financial OfficerJan 23, 2023 Sale$0.6017,76910,622154,736Jan 25, 2023, 05:28 PM
Rosenberger BrianVP, Commercial & Business Dev.Jan 23, 2023 Sale$0.6012,6637,57094,848Jan 25, 2023, 05:26 PM
ANIDO ARMANDOChairman & Chief Exec. OfficerJan 23, 2023 Sale$0.6035,45321,194576,235Jan 25, 2023, 05:25 PM
Sebree Terri BPresidentJul 19, 2022 Sale$1.108,2819,109367,865Jul 20, 2022, 04:08 PM
Rosenberger BrianVP, Commercial & Business Dev.Jul 19, 2022 Sale$1.104,2894,718107,511Jul 20, 2022, 04:06 PM
Fickenscher James EChief Financial OfficerJul 19, 2022 Sale$1.106,0136,614172,505Jul 20, 2022, 04:05 PM
ANIDO ARMANDOChairman & CEOJul 19, 2022 Sale$1.1011,89913,089611,688Jul 20, 2022, 04:05 PM
KISNER DANIEL LDirectorJun 14, 2022 Sale$1.01404028,069Jun 16, 2022, 09:53 PM
FEDERICI WILLIAM JDirectorJun 14, 2022 Sale$1.01404028,069Jun 16, 2022, 09:52 PM
Stephenson PamelaDirectorJun 14, 2022 Sale$1.01404028,069Jun 16, 2022, 09:51 PM
MOCH KENNETH IDirectorJun 14, 2022 Sale$1.01404028,069Jun 16, 2022, 09:50 PM
COOPER WARREN DDirectorJun 14, 2022 Sale$1.01404028,069Jun 16, 2022, 09:49 PM
Butler John P.DirectorJun 14, 2022 Sale$1.01535433,056Jun 16, 2022, 09:48 PM
Butler John P.DirectorAug 22, 2018 Buy$6.435,00032,1535,000Aug 22, 2018, 04:39 PM
ANIDO ARMANDOChairman & Chief Exec. OfficerAug 06, 2018 Buy$5.9615,00089,423352,512Aug 07, 2018, 04:32 PM
Hanlon Suzanne M.Sec, VP & General CounselAug 06, 2018 Buy$5.803,80022,04843,693Aug 07, 2018, 04:30 PM
Sebree Terri BPresidentAug 06, 2018 Buy$5.793,80022,013182,546Aug 07, 2018, 04:29 PM
Fickenscher James EChief Financial OfficerAug 06, 2018 Buy$5.978,51850,84220,718Aug 07, 2018, 04:28 PM
RAPP MICHAEL10% OwnerMay 30, 2018 Buy$10.455,88561,4981,500,000May 31, 2018, 09:26 AM
RAPP MICHAEL10% OwnerMay 02, 2018 Buy$10.4615,000156,9451,494,115May 02, 2018, 05:38 PM
RAPP MICHAEL10% OwnerMar 22, 2018 Buy$9.2810,00092,7901,479,115Mar 23, 2018, 09:30 AM
RAPP MICHAEL10% OwnerJan 02, 2018 Buy$12.9915,000194,8471,469,115Jan 03, 2018, 06:05 AM
RAPP MICHAEL10% OwnerOct 23, 2017 Buy$9.9425,745255,7951,454,115Oct 23, 2017, 07:25 PM
RAPP MICHAEL10% OwnerOct 20, 2017 Buy$9.7830,000293,5381,428,370Oct 23, 2017, 07:25 PM
RAPP MICHAEL10% OwnerOct 19, 2017 Buy$9.5944,255424,4051,398,370Oct 23, 2017, 07:25 PM
ANIDO ARMANDOChairman & Chief Exec. OfficerMay 15, 2017 Buy$19.571,50029,355337,512May 16, 2017, 08:50 AM
ANIDO ARMANDOChairman & Chief Exec. OfficerMay 12, 2017 Buy$19.763,50069,160336,012May 16, 2017, 08:50 AM
Fickenscher James EChief Financial OfficerMay 12, 2017 Buy$19.825,200103,06412,200May 16, 2017, 08:50 AM
RAPP MICHAEL10% OwnerDec 29, 2016 Buy$15.8510,000158,5001,354,115Dec 29, 2016, 09:54 PM
Fickenscher James EChief Financial OfficerDec 07, 2016 Buy$14.034,00056,1207,000Dec 08, 2016, 02:01 PM
Fickenscher James EChief Financial OfficerDec 06, 2016 Buy$14.153,00042,4503,000Dec 08, 2016, 02:01 PM
Hanlon Suzanne M.Sec, General Counsel & VP HRAug 05, 2015 Buy$17.923,00053,7603,000Aug 17, 2016, 02:19 PM
Hanlon Suzanne M.Sec, General Counsel & VP HRAug 16, 2016 Sale$10.533,00031,5900Aug 17, 2016, 02:19 PM
BARON RICHARD AChief Financial OfficerSep 11, 2015 Option Exercise$3.9815,95763,50915,957Sep 15, 2015, 01:48 PM
HARRISON THOMAS LDirectorAug 10, 2015 Buy$14.0012,500175,00012,500Aug 12, 2015, 11:48 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Sebree Terri BPresident09/13/202316,440
Rosenberger BrianVP, Commercial & Business Dev.09/13/20238,499
Fickenscher James EChief Financial Officer09/13/202311,929
Jones Kenneth TSee Remarks09/13/20233,321
ANIDO ARMANDOChairman & Chief Exec. Officer09/13/202323,637
Stephenson PamelaDirector06/14/202340
MOCH KENNETH IDirector06/14/202340
KISNER DANIEL LDirector06/14/202340
FEDERICI WILLIAM JDirector06/14/202340
Butler John P.Director06/14/202340
COOPER WARREN DDirector06/14/202340
Parker Albert PChief Legal Officer02/15/20231,719
Rosenberger BrianVP, Commercial & Business Dev.02/08/20233,069
Fickenscher James EChief Financial Officer02/08/20233,903
Sebree Terri BPresident02/08/20235,949
ANIDO ARMANDOChairman & Chief Exec. Officer02/08/20237,484
Parker Albert PChief Legal Officer02/08/20233,259
ANIDO ARMANDOChairman & Chief Exec. Officer02/01/20236,979
Parker Albert PChief Legal Officer02/01/20233,477
Rosenberger BrianVP, Commercial & Business Dev.02/01/20232,862
Fickenscher James EChief Financial Officer02/01/20233,528
Sebree Terri BPresident02/01/20235,548
Sebree Terri BPresident01/23/202314,742
Fickenscher James EChief Financial Officer01/23/202310,622
Rosenberger BrianVP, Commercial & Business Dev.01/23/20237,570
ANIDO ARMANDOChairman & Chief Exec. Officer01/23/202321,194
Sebree Terri BPresident07/19/20229,109
Rosenberger BrianVP, Commercial & Business Dev.07/19/20224,718
Fickenscher James EChief Financial Officer07/19/20226,614
ANIDO ARMANDOChairman & CEO07/19/202213,089
KISNER DANIEL LDirector06/14/202240
FEDERICI WILLIAM JDirector06/14/202240
Stephenson PamelaDirector06/14/202240
MOCH KENNETH IDirector06/14/202240
COOPER WARREN DDirector06/14/202240
Butler John P.Director06/14/202254
Butler John P.Director08/22/201832,153
ANIDO ARMANDOChairman & Chief Exec. Officer08/06/201889,423
Hanlon Suzanne M.Sec, VP & General Counsel08/06/201822,048
Sebree Terri BPresident08/06/201822,013
Fickenscher James EChief Financial Officer08/06/201850,842
RAPP MICHAEL10% Owner05/30/201861,498
RAPP MICHAEL10% Owner05/02/2018156,945
RAPP MICHAEL10% Owner03/22/201892,790
RAPP MICHAEL10% Owner01/02/2018194,847
RAPP MICHAEL10% Owner10/23/2017255,795
RAPP MICHAEL10% Owner10/20/2017293,538
RAPP MICHAEL10% Owner10/19/2017424,405
ANIDO ARMANDOChairman & Chief Exec. Officer05/15/201729,355
ANIDO ARMANDOChairman & Chief Exec. Officer05/12/201769,160
Fickenscher James EChief Financial Officer05/12/2017103,064
RAPP MICHAEL10% Owner12/29/2016158,500
Fickenscher James EChief Financial Officer12/07/201656,120
Fickenscher James EChief Financial Officer12/06/201642,450
Hanlon Suzanne M.Sec, General Counsel & VP HR08/05/201553,760
Hanlon Suzanne M.Sec, General Counsel & VP HR08/16/201631,590
BARON RICHARD AChief Financial Officer09/11/201563,509
HARRISON THOMAS LDirector08/10/2015175,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ZYNERBA PHARMACEUTICALS INC
STOCK BUYBACKS FOR ZYNERBA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
3.55%
1Q
06/30/2023
12/31/2022
11.06%
2Q
06/30/2023
09/30/2022
14.64%
3Q
06/30/2023
06/30/2022
21.12%
4Q
06/30/2023
03/31/2022
24.43%
5Q
06/30/2023
12/31/2021
24.63%
6Q
06/30/2023
09/30/2021
25.09%
7Q
06/30/2023
06/30/2021
25.17%
8Q
06/30/2023
03/31/2021
25.17%
9Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
3.55%
1Q
12/31/2022
11.06%
2Q
09/30/2022
14.64%
3Q
06/30/2022
21.12%
4Q
03/31/2022
24.43%
5Q
12/31/2021
24.63%
6Q
09/30/2021
25.09%
7Q
06/30/2021
25.17%
8Q
03/31/2021
25.17%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ZYNERBA PHARMACEUTICALS INC
LOADING...